Cargando…

T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus

BACKGROUND: T cells regulate the adaptive immune response and have altered function in autoimmunity. Systemic Lupus Erythematosus (SLE) has great diversity of presentation and treatment response. Peripheral blood component gene expression affords an efficient platform to investigate SLE immune dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradley, Sean J., Suarez-Fueyo, Abel, Moss, David R., Kyttaris, Vasileios C., Tsokos, George C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636226/ https://www.ncbi.nlm.nih.gov/pubmed/26544975 http://dx.doi.org/10.1371/journal.pone.0141171

Ejemplares similares

Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus
por: Suarez-Fueyo, Abel, et al.
Publicado: (2019)

Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signaling
por: Grammatikos, Alexandros P., et al.
Publicado: (2013)

Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus
por: Karampetsou, Maria P., et al.
Publicado: (2017)

Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
por: Kyttaris, Vasileios C., et al.
Publicado: (2013)

Polyarticular septic arthritis caused by Staphylococcus lugdunensis in a patient with systemic lupus erythematosus
por: Laloo, Anita, et al.
Publicado: (2018)

IL-17 in Systemic Lupus Erythematosus
por: Crispín, José C., et al.
Publicado: (2010)

Cytokines in Systemic Lupus Erythematosus
por: Poole, Brian D., et al.
Publicado: (2010)

Abnormalities of T cell signaling in systemic lupus erythematosus
por: Moulton, Vaishali R, et al.
Publicado: (2011)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Cytokines in Systemic Lupus Erythematosus 2011
por: Poole, Brian D., et al.
Publicado: (2012)

Journal Club: Anti‐CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus
por: Boulougoura, Afroditi, et al.
Publicado: (2023)

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus
por: Mizui, Masayuki, et al.
Publicado: (2018)

Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
por: Katsuyama, Takayuki, et al.
Publicado: (2018)

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections
por: Katsuyama, Eri, et al.
Publicado: (2020)

The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
por: Lieberman, Linda A., et al.
Publicado: (2010)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Novel Treatments in Lupus
por: Vukelic, Milena, et al.
Publicado: (2018)

Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus
por: Koga, Tomohiro, et al.
Publicado: (2021)

Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells
por: Li, Hao, et al.
Publicado: (2020)

Transcriptomic studies of systemic lupus erythematosus
por: Nakano, Masahiro, et al.
Publicado: (2021)

Estrogen‐Induced hsa‐miR‐10b‐5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down‐Regulates Serine/Arginine‐Rich Splicing Factor 1
por: Ramanujan, Suruchi A., et al.
Publicado: (2021)

Nonisomorphic and Nonisotopic Multidermatomal Discoid Lupus Erythematosus – A Rare Subtype of Cutaneous Lupus Erythematosus
por: Choudhary, Sanjiv, et al.
Publicado: (2020)

B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity
por: Abernathy-Close, Lisa, et al.
Publicado: (2021)

Journal Club: Efficacy and Safety of Voclosporin Versus Placebo for Lupus Nephritis (AURORA 1): A Double‐Blind, Randomized, Multicenter, Placebo‐Controlled, Phase 3 Trial
por: Rubio, Jose, et al.
Publicado: (2021)

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus
por: Romero-Ramírez, Sandra, et al.
Publicado: (2023)

Protein phosphatase 2A is requisite for the function of regulatory T cells
por: Apostolidis, Sokratis A., et al.
Publicado: (2016)

Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus
por: Li, Huiyan, et al.
Publicado: (2022)

Review: transcriptome and trans-omics analysis of systemic lupus erythematosus
por: Fujio, Keishi, et al.
Publicado: (2020)

Transcriptomic analysis of human endogenous retroviruses in systemic lupus erythematosus
por: Iñiguez, Luis P., et al.
Publicado: (2019)

Integrative Analysis for Elucidating Transcriptomics Landscapes of Systemic Lupus Erythematosus
por: Zhang, Haihong, et al.
Publicado: (2021)

Systemic lupus erythematosus.
por: Richardson, J.
Publicado: (1969)

Systemic Lupus Erythematosus
por: Peng, Stanford
Publicado: (1993)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

Systemic Lupus Erythematosus
por: Putterman, Chaim, et al.
Publicado: (2012)

Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2012)

Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
por: Cooper, Elizabeth E., et al.
Publicado: (2021)

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Superior Mesenteric Artery Syndrome in Systemic Lupus Erythematosus
por: Bradley, India C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ig7edrvmqq7brkckhoate5kmvo